American Society of Hematology

banner image

59th ASH Annual Meeting & Exposition

Advance registration for the 59th ASH Annual Meeting is now open.

Learn more
banner image

Now Available for Comment: Draft Recommendations on VTE

ASH is seeking public comment on draft recommendations for two guidelines on venous thromboembolism (VTE).

Learn more
banner image

MDS Summit

Improve performance diagnosis and treatment of patients with myelodysplastic syndromes (MDS). Attend one of three free CME summits.

Learn more

Support Medical Research

Urge your members of Congress to support continued medical research funding.

Take action
Find a Hematologist

Find a Hematologist

Search a database of practicing hematologists in your area.

Learn more
Support Hematology

ASH Foundation

Help move hematology forward by supporting research, career development, and quality care and education programs.

Learn more
Join ASH

ASH Membership

Become part of a global network of more than 17,000 hematologists working to conquer blood diseases.

Learn more
View all press releases
  • NCATS Seeking Information on Opportunities and Challenges for Platform Vector Human Gene Therapy Trials in Rare Diseases

    The National Center for Advancing Translational Sciences (NCATS) released a request for information soliciting input on the use of viral vectors as platforms for therapeutic gene delivery to specific organs or cell types, and how such platforms might be developed most efficiently in clinical trials for the treatment of multiple diseases.

  • Congress Changes Stance on ACA Repeal and Replace

    On July 13, 2017, the U.S. Senate released an updated version of the Better Care Reconciliation Act (BCRA), legislation to repeal large provisions of the Affordable Care Act (ACA).

  • DEA Eliminates Grace Period for Registration Renewal

    Through a notice on its website, the Drug Enforcement Administration (DEA) recently announced significant changes to its registration renewal process. Effective January 1, 2017, the DEA is eliminating the informal grace period which the agency has previously allowed for registrants to renew their registrations. 

  • CMS Announces End to Medicare Part B Drug Payment Model

    On December 15, 2016, the Centers for Medicare and Medicaid Services (CMS) announced the cancellation of Medicare Part B Drug Payment Model.  CMS initially proposed the demonstration on March 8, 2016 to test new models in how physician-administered drugs are paid under the Medicare program.

View all policy news
  • Test January-February 2018 Feature Article

    One of the most common clinical problems that hematologists deal with is diagnosis and management of patients with prolonged, excessive, or unusual bleeding. As a pediatric hematologist interested in hemorrhagic disorders for three decades, I thought until recently that I had "seen it all." But I was wrong. This past January, I was asked by the ASH Communications Department staff to consider working with the National Geographic Channel in filming a story about a 13-yearold girl in India who was said to "cry tears of blood."

  • Test November-December 2017 Feature Article

    In April, medical professionals from the United States and Mexico met in Mexico City to kick off a pilot program designed to standardize cytogenetics laboratory procedures for the diagnosis of hematologic malignancies in Mexico. This meeting came about after AMEH (La Agrupación Mexicana para el Estudio la Hematología [the Mexican hematology association]) asked ASH to help investigate ways to build capacity for hematologic cytogenetics laboratories in Mexico.

  • A Woman With Hypergammaglobulinemia and Diffuse Lymphadenopathy

    Take the image challenge to determine the diagnosis for a woman with hypergammaglobulinemia and diffuse lymphadenopathy.

  • How We Mark Time and How Time Marks Us

    Dr. Gotlib discusses the road to approval of midostaurin for the treatment of advanced systemic mastocytosis.

View all Hematologist articles